The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Christoph U. Correll

The Zucker Hillside Hospital

Division of Psychiatry Research

North Shore-LIJ Health System




Name/email consistency: high



  • The Zucker Hillside Hospital, Division of Psychiatry Research, North Shore-LIJ Health System, 75-59, USA. 2012
  • The Zucker Hillside Hospital, Psychiatry Research, 75-59 263rd St, Glen Oaks, USA. 2005 - 2011
  • Psychiatry Research Division, Zucker Hillside Hospital, Long Island Jewish Medical Center, Glen Oaks, USA. 2003 - 2010
  • Albert Einstein College of Medicine, Department of Psychiatry, Bronx, USA. 2007
  • Recognition and Prevention Program, Zucker Hillside Hospital, Queens, New York, USA. 2007


  1. Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice. Correll, C.U., Gallego, J.A. Psychiatr. Clin. North Am. (2012) [Pubmed]
  2. What are we looking for in new antipsychotics? Correll, C.U. J. Clin. Psychiatry (2011) [Pubmed]
  3. From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics. Correll, C.U. Eur. Psychiatry (2010) [Pubmed]
  4. Findings of a U.S. national cardiometabolic screening program among 10,084 psychiatric outpatients. Correll, C.U., Druss, B.G., Lombardo, I., O'Gorman, C., Harnett, J.P., Sanders, K.N., Alvir, J.M., Cuffel, B.J. Psychiatr. Serv (2010) [Pubmed]
  5. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. Correll, C.U., Sheridan, E.M., DelBello, M.P. Bipolar. Disord (2010) [Pubmed]
  6. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Correll, C.U., Rummel-Kluge, C., Corves, C., Kane, J.M., Leucht, S. Schizophr. Bull (2009) [Pubmed]
  7. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. Correll, C.U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J.M., Malhotra, A.K. JAMA (2009) [Pubmed]
  8. Identification of high-risk coronary heart disease patients receiving atypical antipsychotics: single low-density lipoprotein cholesterol threshold or complex national standard? Correll, C.U., Kane, J.M., Manu, P. J. Clin. Psychiatry (2008) [Pubmed]
  9. Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients. Correll, C.U. Int. Rev. Psychiatry (2008) [Pubmed]
  10. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Correll, C.U., Frederickson, A.M., Kane, J.M., Manu, P. Bipolar. Disord (2008) [Pubmed]
  11. Tardive dyskinesia and new antipsychotics. Correll, C.U., Schenk, E.M. Curr. Opin. Psychiatry (2008) [Pubmed]
  12. Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes. Correll, C.U. J. Am. Acad. Child. Adolesc. Psychiatry (2008) [Pubmed]
  13. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. Correll, C.U. J. Clin. Psychiatry (2008) [Pubmed]
  14. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia. Correll, C.U., Smith, C.W., Auther, A.M., McLaughlin, D., Shah, M., Foley, C., Olsen, R., Lencz, T., Kane, J.M., Cornblatt, B.A. J. Child. Adolesc. Psychopharmacol (2008) [Pubmed]
  15. Elevated cardiovascular risk in patients with bipolar disorder: when does it start and where does it lead?. Correll, C.U. J. Clin. Psychiatry (2008) [Pubmed]
  16. Early identification and high-risk strategies for bipolar disorder. Correll, C.U., Penzner, J.B., Lencz, T., Auther, A., Smith, C.W., Malhotra, A.K., Kane, J.M., Cornblatt, B.A. Bipolar. Disord (2007) [Pubmed]
  17. One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review. Correll, C.U., Kane, J.M. J. Child. Adolesc. Psychopharmacol (2007) [Pubmed]
  18. Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. Correll, C.U., Penzner, J.B., Frederickson, A.M., Richter, J.J., Auther, A.M., Smith, C.W., Kane, J.M., Cornblatt, B.A. Schizophr. Bull (2007) [Pubmed]
  19. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. Correll, C.U. J. Am. Acad. Child. Adolesc. Psychiatry (2007) [Pubmed]
  20. Does antipsychotic polypharmacy increase the risk for metabolic syndrome?. Correll, C.U., Frederickson, A.M., Kane, J.M., Manu, P. Schizophr. Res. (2007) [Pubmed]
  21. Balancing efficacy and safety in treatment with antipsychotics. Correll, C.U. CNS. Spectr (2007) [Pubmed]
  22. Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents. Correll, C.U., Penzner, J.B., Parikh, U.H., Mughal, T., Javed, T., Carbon, M., Malhotra, A.K. Child. Adolesc. Psychiatr. Clin. N. Am (2006) [Pubmed]
  23. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. Correll, C.U., Carlson, H.E. J. Am. Acad. Child. Adolesc. Psychiatry (2006) [Pubmed]
  24. Prospective study of adolescents with subsyndromal psychosis: characteristics and outcome. Correll, C.U., Lencz, T., Smith, C.W., Auther, A.M., Nakayama, E.Y., Hovey, L., Olsen, R., Shah, M., Foley, C., Cornblatt, B.A. J. Child. Adolesc. Psychopharmacol (2005) [Pubmed]
  25. Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story?. Correll, C.U. J. Clin. Psychiatry (2005) [Pubmed]
  26. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Correll, C.U., Leucht, S., Kane, J.M. Am. J. Psychiatry (2004) [Pubmed]
  27. Early prediction of antipsychotic response in schizophrenia. Correll, C.U., Malhotra, A.K., Kaushik, S., McMeniman, M., Kane, J.M. Am. J. Psychiatry (2003) [Pubmed]
WikiGenes - Universities